Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Recent Advances In MR Contrast Media

V. Dousset
Published 2001 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
The need for contrast agents in MR imaging has been challenged over the past decade. The contrast obtained spontaneously between tissues does not appear sufficient for diagnosis or for the characterization of the nature and function of pathological processes. Today, small size molecules of gadolinium are widely used in a clinical setting and a large variety of contrasts can be obtained. New contrast agents are appearing with the goal of providing more specific information.
This paper references
Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review.
B. Bonnemain (1998)
In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance
V. Dousset (1999)
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
R. Weissleder (1990)
Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time.
A. G. Sorensen (1999)
Detectability of Early Brain Meningitis with Magnetic Resonance Imaging
V. Runge (1995)
MR imaging of phagocytosis in experimental gliomas.
C. Zimmer (1995)
Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging.
V. Dousset (1992)
Magnetically labeled cells can be detected by MR imaging
R. Weissleder (1997)
Improvement of post-gadolinium contrast with magnetization transfer
P. Huot (1997)
MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.
R. Guimarães (1994)
Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis.
V. Dousset (1999)
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
R. Martin (1995)
MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
M. Harisinghani (1999)
Improved delineation of human brain tumors on MR images using a long‐circulating, superparamagnetic iron oxide agent
W. S. Enochs (1999)
An intelligent MRI contrast agent for tumor sensing.
M. Mikawa (2002)
Susceptibility contrast imaging of cerebral blood volume: Human experience
B. R. Rosen (1991)
Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo
S. D. Wolff (1989)
Study of Moderately Rapid Chemical Exchange Reactions by Means of Nuclear Magnetic Double Resonance
S. Forsén (1963)
Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
R. Weissleder (1990)
Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography
A. Taylor (1999)
Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer.
Y. Anzai (1994)

Semantic Scholar Logo Some data provided by SemanticScholar